Biosimilars in Oncology & Autoimmune Disorders

Oncology and autoimmune disorders represent some of the most promising and rapidly expanding therapeutic areas for biosimilar adoption. With the high cost of originator biologics in these domains, biosimilars offer transformative opportunities for improving access, reducing healthcare expenditures, and broadening treatment reach. This segment highlights the clinical efficacy, safety, and real-world performance of biosimilars used in cancer treatment, such as rituximab, trastuzumab, and bevacizumab, alongside agents targeting autoimmune conditions like infliximab, adalimumab, and etanercept. The focus is on clinical switching data, physician and patient acceptance, market penetration rates, and therapeutic equivalence assessments. Attendees will explore how biosimilars have influenced treatment algorithms, reimbursement strategies, and national health policy. Additionally, innovations in drug delivery, immunogenicity management, and combination regimens are accelerating adoption in sensitive patient populations. As biosimilar pipelines expand into niche and complex biologics, oncology and immunology remain at the forefront of clinical and regulatory breakthroughs. Stakeholders will gain insights into how these therapies can be integrated safely and sustainably into standard-of-care protocols.

    Related Conference of Biosimilars in Oncology & Autoimmune Disorders

    January 29-30, 2026

    19th World Drug Delivery Summit

    Paris, France
    February 10-11, 2026

    40th World Congress on Pharmacology and Therapeutics

    Barcelona, Spain
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, UK
    March 23-24, 2026

    36th Annual European Pharma Congress

    London, UK
    March 24-25, 2026

    11th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France

    Biosimilars in Oncology & Autoimmune Disorders Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in